Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schmid-Burgk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Der Nervenarzt|October 16, 2007
[The problem of epistemology in neuroscience and its consequences to psychiatry]W Schmid-Burgk
Fortschritte Der Neurologie-Psychiatrie|February 1, 1984
[Saccadic eye movements and endogenous psychoses]W Schmid-Burgk
Fortschritte Der Neurologie-Psychiatrie|April 1, 1982
[Influence of protein content on total CSF protein (author's transl)]W Schmid-Burgk, K Vetter
Journal of Neural Transmission. Supplementum|January 1, 1988
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramineR Gieschke, W Schmid-Burgk, R Amrein
Neuropsychobiology|January 1, 1985
Diclofensine and imipramine. A double-blind comparative trial in depressive out-patientsR Capponi, L Hormazabal, W Schmid-Burgk
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 1, 1992
RIMA: a safe concept in the treatment of depression with moclobemideR Amrein, W Hetzel, M Stabl, et al.
International Clinical Psychopharmacology|January 1, 1993
RIMA--a new concept in the treatment of depression with moclobemideR Amrein, W Hetzel, M Stabl, et al.
Journal of Neural Transmission. Supplementum|January 1, 1989
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive statesM Stabl, K Biziére, W Schmid-Burgk, et al.
Neuropsychobiology|January 1, 1983
Saccadic eye movements in psychiatric patientsW Schmid-Burgk, W Becker, R Jürgens, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1981
Levels of total and free tryptophan in the plasma of endogenous and neurotic depressivesW Schmid-Burgk, J S Kim, R Lischewski, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Der Nervenarzt|October 16, 2007
[The problem of epistemology in neuroscience and its consequences to psychiatry]W Schmid-Burgk
Fortschritte Der Neurologie-Psychiatrie|February 1, 1984
[Saccadic eye movements and endogenous psychoses]W Schmid-Burgk
Fortschritte Der Neurologie-Psychiatrie|April 1, 1982
[Influence of protein content on total CSF protein (author's transl)]W Schmid-Burgk, K Vetter
Journal of Neural Transmission. Supplementum|January 1, 1988
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramineR Gieschke, W Schmid-Burgk, R Amrein
Neuropsychobiology|January 1, 1985
Diclofensine and imipramine. A double-blind comparative trial in depressive out-patientsR Capponi, L Hormazabal, W Schmid-Burgk
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 1, 1992
RIMA: a safe concept in the treatment of depression with moclobemideR Amrein, W Hetzel, M Stabl, et al.
International Clinical Psychopharmacology|January 1, 1993
RIMA--a new concept in the treatment of depression with moclobemideR Amrein, W Hetzel, M Stabl, et al.
Journal of Neural Transmission. Supplementum|January 1, 1989
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive statesM Stabl, K Biziére, W Schmid-Burgk, et al.
Neuropsychobiology|January 1, 1983
Saccadic eye movements in psychiatric patientsW Schmid-Burgk, W Becker, R Jürgens, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1981
Levels of total and free tryptophan in the plasma of endogenous and neurotic depressivesW Schmid-Burgk, J S Kim, R Lischewski, et al.
Pageof 2